Steth IO
https://stethio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Steth IO
Finance Watch: No New IPOs, But Two Firms Take The SPAC Route
Public Company Edition: NewAmsterdam grossed $328m in its SPAC merger, while Liminatus may raise up to $316m in a new SPAC deal. Also, Intellia and Iveric grossed $300m each in follow-on offerings, bluebird sold a PRV for $102m and MEI ends zandelisib development resulting in layoffs.
Emerging Views On Emerging Markets: Goldman Sachs Health Care Conference
PharmAsia News takes a closer look at presentations by Abbott, Amgen, Medtronic, Mylan, Shire, Stryker and Valeant.
In Brief
ERSP clarifies requirements for quantified claims; food, veterinary medicine under same FDA office; FDA hosts forum on food safety regs; FDA OKs Reddy’s pediatric Allegra equivalent; Valeant finalizes Natur Produkt acquisition; FTC Chairman Jon Leibowitz to step down.
People In Brief
Steinford heads Doctor’s Best; NattoPharma names Vik CEO; Valeant President De Silva departing; Bayer’s Wenning moves to supervisory board chair; GMA strengthens federal affairs team; more People In Brief.
Company Information
- Industry
-
Medical Devices
- Monitoring Equipment & Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice